Daniel Ryu

467 total citations
16 papers, 231 citations indexed

About

Daniel Ryu is a scholar working on Physiology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Daniel Ryu has authored 16 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 6 papers in Neurology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daniel Ryu's work include Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Daniel Ryu is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Daniel Ryu collaborates with scholars based in United States, United Kingdom and South Korea. Daniel Ryu's co-authors include Todd E. Golde, Benoit I. Giasson, Paramita Chakrabarty, Mayur Parmar, Hyo‐Jin Park, Pedro E. Cruz, Nikolaus R. McFarland, Marshall S. Goodwin, Dennis W. Dickson and Cara L. Croft and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Daniel Ryu

16 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Ryu United States	9	107	81	77	66	61	16	231
Shamiram Melhem Netherlands	12	102 1.0×	107 1.3×	69 0.9×	113 1.7×	53 0.9×	16	256
Connor M. Wander United States	7	108 1.0×	65 0.8×	44 0.6×	130 2.0×	75 1.2×	9	257
Michaela Kaiserová Czechia	11	98 0.9×	205 2.5×	48 0.6×	74 1.1×	74 1.2×	29	292
Linda Rousseau United States	7	155 1.4×	173 2.1×	82 1.1×	105 1.6×	63 1.0×	7	325
Constanze Depp Germany	7	85 0.8×	59 0.7×	117 1.5×	111 1.7×	67 1.1×	13	295
Hanneke Geut Netherlands	10	83 0.8×	121 1.5×	61 0.8×	77 1.2×	54 0.9×	13	232
Aitana Sogorb‐Esteve United Kingdom	8	118 1.1×	73 0.9×	46 0.6×	65 1.0×	33 0.5×	15	207
Celeste Sassi United States	9	138 1.3×	61 0.8×	70 0.9×	129 2.0×	64 1.0×	13	281
Audrey Coens France	8	167 1.6×	86 1.1×	95 1.2×	164 2.5×	109 1.8×	8	337

Countries citing papers authored by Daniel Ryu

Since Specialization

Citations

This map shows the geographic impact of Daniel Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ryu more than expected).

Fields of papers citing papers by Daniel Ryu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ryu. The network helps show where Daniel Ryu may publish in the future.

Co-authorship network of co-authors of Daniel Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ryu. A scholar is included among the top collaborators of Daniel Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ryu. Daniel Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Roemeling, Christina A. Von, Changlin Yang, Bently P. Doonan, et al.. (2024). Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade. Nature Communications. 15(1). 5871–5871. 5 indexed citations

Croft, Cara L., Daniel Ryu, Marshall S. Goodwin, et al.. (2022). Optical pulse labeling studies reveal exogenous seeding slows α-synuclein clearance. npj Parkinson s Disease. 8(1). 173–173. 1 indexed citations

McFarland, Karen N., Mariet Allen, Christian Lessard, et al.. (2022). Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways. Alzheimer s Research & Therapy. 14(1). 104–104. 10 indexed citations

Chen, Kai, Yuka A. Martens, Axel Meneses, et al.. (2022). LRP1 is a neuronal receptor for α-synuclein uptake and spread. Molecular Neurodegeneration. 17(1). 57–57. 56 indexed citations

McFarland, Karen N., Guilian Xu, Daniel Ryu, et al.. (2021). Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation. Neuropathology and Applied Neurobiology. 48(2). e12779–e12779. 9 indexed citations

Croft, Cara L., Marshall S. Goodwin, Daniel Ryu, et al.. (2021). Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions. Acta Neuropathologica. 141(3). 359–381. 15 indexed citations

Cruz, Pedro E., Daniel Ryu, Todd E. Golde, et al.. (2020). Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy. Molecular Neurobiology. 57(4). 1986–2001. 12 indexed citations

Ryu, Daniel, et al.. (2020). Effect of soluble interleukin‐10 receptor expression in mouse models of Alzheimer’s disease. Alzheimer s & Dementia. 16(S2). 1 indexed citations

Ryu, Daniel, et al.. (2020). Exploring the pathologic synergy between amyloid β and tau. Alzheimer s & Dementia. 16(S3). 1 indexed citations

10.

Croft, Cara L., Xuefei Liu, Daniel Ryu, et al.. (2020). Elucidating the relationship between TGF‐β signaling and Alzheimer’s disease. Alzheimer s & Dementia. 16(S2). 2 indexed citations

11.

Lin, Wen-Lang, Cara J. Riffe, Daniel Ryu, et al.. (2019). Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy. Human Molecular Genetics. 28(19). 3255–3269. 27 indexed citations

12.

Croft, Cara L., Pedro E. Cruz, Daniel Ryu, et al.. (2019). rAAV-based brain slice culture models of Alzheimer’s and Parkinson’s disease inclusion pathologies. The Journal of Experimental Medicine. 216(3). 539–555. 35 indexed citations

13.

Ayers, Jacob I., Kristen Skruber, Hilda Brown, et al.. (2018). ALS-Linked SOD1 Mutants Enhance Neurite Outgrowth and Branching in Adult Motor Neurons. iScience. 11. 294–304. 32 indexed citations

14.

McFarland, Nikolaus R., et al.. (2018). Rab8a protects against alpha-synuclein toxicity in a rat model of Parkinsonism (P3.049). Neurology. 90(15_supplement). 3 indexed citations

15.

Xu, Wei, et al.. (2018). Wind Shielding Estimation of a Vessel in Side by Side Configuration using Disturbed Velocity Field from CFD. 1 indexed citations

16.

Park, Hyo‐Jin, Daniel Ryu, Mayur Parmar, Benoit I. Giasson, & Nikolaus R. McFarland. (2017). The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome. PLoS ONE. 12(9). e0184262–e0184262. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact